Aethlon Medical
AEMD
12 hedge funds and large institutions have $4.08M invested in Aethlon Medical in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 8 closing their positions.
186% more capital invested
Capital invested by funds: $1.43M → $4.08M (+$2.66M)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0.41% less ownership
Funds ownership: 5.81% → 5.4% (-0.41%)
25% less funds holding
Funds holding: 16 → 12 (-4)
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
96% less call options, than puts
Call options by funds: $3K | Put options by funds: $74K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.17M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$104K |
| 3 |
Two Sigma Investments
New York
|
+$92.1K |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$57.6K |
| 5 |
State Street
Boston,
Massachusetts
|
+$57.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$622K |
| 2 |
VF
Virtu Financial
New York
|
-$40K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$34.5K |
| 4 |
CCP
Cardan Capital Partners
Denver,
Colorado
|
-$32K |
| 5 |
FMBTD
First Midwest Bank Trust Division
Joliet,
Illinois
|
-$31K |
AEMD Hedge Fund Activity: Q2 2021 in Review
12 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q2 2021, worth a combined $4.08M — up 186% from $1.43M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of AEMD and 4 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Vanguard Group, adding an estimated $1.17M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $622K sold.
- 12 institutional investors held Aethlon Medical (AEMD) as of Q2 2021, down from 16 in Q1 2021.
- Funds reported $4.08M of Aethlon Medical stock for Q2 2021, up 186% quarter-over-quarter.
- 4 funds opened new Aethlon Medical positions in Q2 2021 and 8 closed out, a net change of -4 holders.
- The largest Aethlon Medical buyer in Q2 2021 was Vanguard Group, an estimated $1.17M added.
- The largest Aethlon Medical seller in Q2 2021 was Renaissance Technologies, an estimated $622K sold.
Based on aggregated 13F filings for Q2 2021.